A low-density mass is an area on a CT scan (or sometimes another imaging study) that appears darker than the surrounding tissue because it absorbs fewer X-rays. This darker appearance usually means the mass contains material like fluid, fat, or a mix of both, rather than solid tissue or bone. Finding one on a scan doesn’t automatically mean something dangerous is happening. In many cases, low-density masses turn out to be cysts, fatty growths, or other benign findings.
How CT Scans Measure Density
CT scanners assign every tissue in your body a number on the Hounsfield unit (HU) scale, which measures how much each tissue absorbs X-rays. Water sits at 0 HU, air at negative 1,000, and dense cortical bone at around positive 1,000. Fat falls in the negative 30 to negative 70 range, muscle and soft tissue land around 20 to 40, and simple fluid (like the contents of a cyst) measures between 0 and 30.
When a radiologist calls a mass “low density,” they mean its Hounsfield number is lower than the organ or tissue around it. A mass in the liver that measures 10 HU, for example, is much darker than the normal liver tissue at 40 to 60 HU. That gap tells the radiologist something about what the mass is made of: primarily fluid, fat, or tissue with very little blood supply.
Common Benign Causes
The most frequent explanation for a low-density mass is a simple cyst, which is essentially a fluid-filled sac with a thin wall. Cysts are extremely common in the kidneys, liver, ovaries, and spleen. On a contrast-enhanced CT, a homogeneous (uniform-looking) renal mass measuring between negative 10 and 20 HU is considered a benign cyst and requires no further workup at all. Even masses measuring up to 30 HU on a contrast-enhanced scan are increasingly recognized as benign cysts that can safely be left alone, as long as they appear uniform with no internal walls, thickening, or calcifications.
Lipomas are another very common low-density finding. These are benign collections of fat, and they typically measure between negative 65 and negative 120 HU on CT, which is similar to the fat just under your skin. When a mass falls clearly in that fat-density range, the diagnosis is usually straightforward.
Other benign possibilities include:
- Abscesses: pockets of infection that appear as low-density collections, sometimes with a rim of enhancement after contrast dye
- Hemangiomas: clusters of blood vessels, particularly common in the liver and spleen (hemangiomas are the most common benign tumor of the spleen, found in up to 14% of people at autopsy)
- Focal fatty change: patches of fat deposited within an organ, especially the liver, that show low density on CT but don’t distort or push aside the organ’s normal blood vessels
- Seromas or lymphoceles: collections of clear fluid that can form after surgery or injury
In the spleen, about 80% of cysts are “false cysts,” meaning they developed after trauma, infection, or a previous area of reduced blood flow rather than being something you were born with. These are typically harmless and found incidentally.
When Low Density Can Signal Something Serious
Some cancerous masses also appear low density on CT, particularly when they outgrow their own blood supply and develop areas of dead tissue (necrosis) inside. Certain tumors, like some bile duct cancers in the liver, show up as low-density lesions. In the lungs, small, poorly defined low-density nodules can sometimes represent early-stage adenocarcinoma.
Several imaging features raise concern that a low-density mass could be malignant rather than benign. The signs with the greatest specificity for cancer include internal necrosis, involvement of nearby bone or major blood vessels, and a diameter larger than about 6.6 centimeters. A deep location (below the layer of connective tissue that separates superficial from deep compartments) and a heterogeneous, uneven internal appearance also increase suspicion. By contrast, a small, well-defined, uniform mass sitting near the surface is far more likely to be harmless.
Irregular borders and mixed internal density (areas of different brightness within the same mass) are less reliable on their own, but when combined with large size and deep location, they form a pattern radiologists take seriously.
What Contrast Dye Reveals
One of the most important tools for interpreting a low-density mass is contrast enhancement. During a contrast-enhanced CT, iodine-based dye is injected into a vein. Tissues with an active blood supply absorb the dye and appear brighter on the scan. A simple cyst has no blood supply inside, so it stays dark after contrast. A solid tumor, on the other hand, typically “lights up” because blood vessels feed it.
The threshold radiologists use is an increase of 20 HU or more after contrast. If a mass jumps by at least that much, it’s considered to be genuinely enhancing, which means it has internal blood flow and needs further investigation. A mass that stays in the same low-density range before and after contrast is much more likely to be a simple cyst or benign fluid collection.
There is a gray zone, though. A homogeneous renal mass measuring 21 to 39 HU on a contrast-enhanced scan sits between the “definitely a cyst” range and the “definitely enhancing” range. Research following patients with these borderline masses for five years found that none of them turned out to be clinically significant. So even in this uncertain range, the odds strongly favor a benign explanation, especially if the mass looks uniform. Newer imaging techniques like dual-energy CT can help resolve these borderline cases without requiring a repeat scan.
What Happens After the Finding
What your doctor recommends next depends on the mass’s size, appearance, location, and how it behaves with contrast. A small, uniform, fluid-density mass in the kidney or liver that measures under 20 HU on contrast-enhanced CT often needs nothing at all. Your radiologist may simply note it and move on.
If the mass is heterogeneous, meaning it has uneven internal texture, visible walls, or areas of different density, further imaging is usually the next step. This might mean a dedicated CT with contrast phases timed to capture how the mass fills with dye, an MRI for better tissue characterization, or contrast-enhanced ultrasound, which is particularly sensitive at detecting blood flow within a mass and doesn’t require kidney-filtered dye.
Biopsy comes into play when imaging alone can’t distinguish between benign and malignant possibilities, particularly for larger masses, masses with worrisome features like necrosis or irregular borders, or masses in locations where the differential diagnosis includes aggressive tumors. Many low-density masses never reach that point. The combination of size, uniformity, density measurements, and contrast behavior gives radiologists enough information to classify them confidently without tissue sampling.
If you’ve received a radiology report mentioning a low-density mass, the most useful thing to look for is whether the report describes the mass as “simple” or “homogeneous” (reassuring) versus “complex,” “heterogeneous,” or “enhancing” (needs further evaluation). Those descriptors carry far more diagnostic weight than the phrase “low density” on its own.